Clinical Trials on Any Cancer Diagnosis

Total 421320 results

Gilead Sciences

Completed

Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 or 24 Weeks in Participants With Chronic Genotype 1 or 2 Hepatitis C Virus Infection Who Have Previously Failed a Direct-Acting Antiviral-Containing Regimen

Hepatitis C Virus Infection

Japan
Merck Sharp & Dohme LLC

Terminated

A Study of the Safety and Efficacy of Pegylated Inferferon Alfa-2b (PEG-Intron™) Versus Pegylated Interferon Alfa-2a (PEGASYS™) in Participants With Chronic Hepatitis B (P08450)

Hepatitis B, Chronic
Nanfang Hospital of Southern Medical University
Tigermed Consulting Co., Ltd

Unknown

Observational Study on Pregnant Women With Chronic Hepatitis B and Their Infants

Hepatitis B, Chronic

China
University of Louisville
James Graham Brown Cancer Center

Terminated

Rituximab Plus Beta-Glucan in Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL)

Lymphoma, Small Lymphocytic | Leukemia, Lymphocytic, Chronic

United States
University of Michigan Rogel Cancer Center

Withdrawn

Radiation Therapy Plus Durvalumab for Tumor-Stage Cutaneous T-Cell Lymphoma

Cutaneous T Cell Lymphoma

United States
Grupo de Investigación Clínica en Oncología Radioterapia

Completed

N2 Lung Cancer Project: Neoadjuvant Treatment Followed Surgery Versus Chemoradiation

Chemoradiation | Surgery | Survival | Non-small-Cell Lung Carcinoma | Stage IIIA-N2

Spain
Hospital Vall d'Hebron

Completed

The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver Transplantation

Hepatitis C Recurrence After Liver Transplant

Spain
European Institute of Oncology

Terminated

R-2cda and Prolongation of Therapy With Rituximab Alone in Chronic Lymphocytic Leukaemia and Small Lymphocytic Lymphoma

Small Lymphocytic Lymphoma | Chronic Lymphocytic Leukaemia

Italy
Cancer Institute and Hospital, Chinese Academy...
Shanxi Province Cancer Hospital; 307 Hospital of PLA; Qilu Hospital of Shandong... and other collaborators

Unknown

Trial of IPGDP Regimen Chemotherapy in Patients With Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type

Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type

China
University of British Columbia

Unknown

Silastic Stent Study

Pituitary Tumour
Gilead Sciences
Chugai Pharmaceutical

Completed

Use-Results Surveillance Study of Sovaldi® Plus Copegus® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection

Hepatitis C Virus Infection

Japan
Bristol-Myers Squibb

Completed

Asunaprevir/Daclatasvir Safety Surveillance in Japanese Patients With Chronic Hepatitis C

Chronic Hepatitis C

Japan
Merck Sharp & Dohme LLC

Completed

PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370)

Fibrosis | Liver Cirrhosis | Hepatitis | Hepatitis C, Chronic
Biotest Pharmaceuticals Corporation

Completed

Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.

Liver Cirrhosis | Hepatitis, Viral, Human | Hepatocellular Carcinoma | Hepatitis C Infection | Viruses

United States
Bristol-Myers Squibb
Janssen Research & Development, LLC

Completed

Study of Daclatasvir (BMS-790052) and Simeprevir (TMC435) in Patients With Genotype 1 Chronic Hepatitis C Virus

Hepatitis C Virus

Argentina, France, United States, Spain, Germany, Hungary
Foundation for Liver Research

Completed

Study Investigating Immunological Effects of Treatment for Chronic Hepatitis C Patients. (CIRES)

Hepatitis C | Immunology | Liver | Regulation

Netherlands
Debiopharm International SA

Terminated

Alisporivir (Deb025) and Boceprevir Triple Therapies in African American Participants Not Previously Treated for Chronic Hepatitis C Genotype 1

Hepatitis C

United States
Novartis
Human Genome Sciences Inc.

Completed

Safety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C Patients

Chronic Hepatitis C

Taiwan, Germany, Greece, Italy, Spain, United Kingdom, France, Canada, Australia, India, Poland, Thailand
The Center for Clinical Research, Winston-Salem...

Completed

High Frequency Stimulation Trials in Patients With Precision Spinal Cord Stimulator System (HFSCS)

Low Back Pain | Chronic Pain | Radiculopathy | Complex Regional Pain Syndrome (CRPS)

United States
Royal Marsden NHS Foundation Trust
Hoffmann-La Roche

Terminated

R-CHOP-B Bevacizumab for Diffuse Large B Cell Lymphoma

B-cell Lymphoma | Non-Hodgkin's Lymphoma

United Kingdom
Hoffmann-La Roche

Completed

Observational Study Evaluating the Quality of Pegylated Interferon Alfa-2a and Ribavirin Treatment for Chronic Hepatitis C in Cooperation With the BNG (Association of German Resident Gastroenterologists)

Chronic Hepatitis C

Germany
Peking University First Hospital

Completed

Prospective Stuy in Evaluating Hepatic Fibrosis Related to Hepatitis B Virus Using Non-invasive Parameters (HBV)

Hepatitis B | Liver Fibrosis

China
Southwest Hospital, China

Unknown

a Clinical Research of Sequential CAR-T Bridging HSCT in the Treatment of Relapse/Refractory B-cell Malignancies

Lymphoma, Large B-Cell, Diffuse | Leukemia, Lymphocytic, Chronic, B-Cell | Lymphoma，Malignant

China
University Hospital, Rouen

Completed

Assessment of Probe Based Confocal Laser Endo-microscopy for In-vivo Diagnosis of Peripheral Lung Nodules and Masses. (NODIVEM)

Pulmonary Nodule Persistent | Malignant Neoplasm of the Respiratory System | Benign Neoplasms of the Respiratory System

France
GlaxoSmithKline

Completed

Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue

Hepatitis B, Chronic

Japan
Genzyme, a Sanofi Company

Completed

Efficacy/Safety of Frontline Alemtuzumab (Campath, MabCampath) vs Chlorambucil in Patients With Progressive B-Cell Lymphocytic Leukemia

B Cell Chronic Lymphocytic Leukemia

United States
Shandong Cancer Hospital and Institute

Unknown

Prophylactic Treatment of Hepatic Dysplastic Nodules in HBsAg Positive Patients

Chronic Hepatitis B | Dysplastic Nodule of Liver
Sahlgrenska University Hospital, Sweden

Completed

Surgical Reconstruction in Ulcerative Colitis With Primary Sclerosing Cholangitis

Ulcerative Colitis | Primary Sclerosing Cholangitis | Complications | Pouchitis

Sweden
Pharco Pharmaceuticals

Unknown

A Study of the Efficacy and Safety of PPI-668 (NS5A Inhibitor) Plus Sofosbuvir, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype-4

Chronic Hepatitis C

Egypt
Center For Hepatitis C, Atlanta, GA

Completed

The SIM-SOF Trial for Hepatitis C

Chronic Hepatitis C

United States
Molecular Templates, Inc.

Withdrawn

Pharmacokinetics (PK), Pharmacodynamics (PD), Safety, Tolerability of Multiple Dose Regimens of MT-3724 for the Treatment of Patients With Relapsed Chronic B-cell Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Small Lymphocytic Leukemia | Chronic B-cell Lymphocytic Leukemia
The HIV Netherlands Australia Thailand Research...
Gilead Sciences; Ministry of Health, Thailand

Completed

Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV Co-infection

HIV Infections | Hepatitis B Virus

Thailand
Bristol-Myers Squibb

No longer available

A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir for the Treatment of Post-Liver Transplant Subjects With Chronic Hepatitis C

Chronic Hepatitis C

United States
Merck Sharp & Dohme LLC

Completed

Boceprevir (SCH 503034) Plus Peg-Intron, With and Without Added Ribavirin, in Patients With Chronic Hepatitis C, Genotype 1, Who Did Not Respond to Previous Treatment With Peginterferon Alfa Plus Ribavirin (Study P03659AM2)(COMPLETED)

Chronic Hepatitis C
Beijing 302 Hospital

Unknown

Pharmacogenomics Study on IL28B Genetic Variants in Chinese Children With Hepatitis C Virus Infection

Chronic Hepatitis C

China
Stefan Schieke MD

Withdrawn

Therapeutic Efficacy of Topical Sirolimus in Early Stage Cutaneous T-cell Lymphoma (CTCL)

Cutaneous T-cell Lymphoma (CTCL)

United States
National Cancer Institute (NCI)

Withdrawn

Lenalidomide in Treating Patients With High-Risk Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic Leukemia

United States
Jia Wei Wang,MD

Unknown

Multicenter and Prospective Clinical Registry Study of Anti-N-methyl-D-aspartate Receptor Encephalitis in Beijing Area (MuPRaNE)

Anti-N-Methyl-D-Aspartate Receptor Encephalitis

China
Medical University of South Carolina
Columbia University; Mclean Hospital

Completed

Acamprosate in Alcoholics With Comorbid Anxiety or Depression

Alcohol Dependence | Generalized Anxiety Disorder | Major Depression | Social Anxiety Disorder

United States
Haukeland University Hospital
Hoffmann-La Roche; Bergen Prison, Norwegian Correctional Service

Terminated

Hepatitis C Treatment of Inmates (PEGPRI)

Chronic Hepatitis C

Norway
New York State Psychiatric Institute

Completed

Memantine Plus Es-citalopram in Elderly Depressed Patients With Cognitive Impairment

Mild Cognitive Impairment | Major Depressive Disorder | Alzheimer's Disease

United States
Beijing Kawin Technology Share-Holding Co., Ltd.

Completed

A Phase Ⅱ Dose-escalating Study of PEG-IFN-SA and Ribavirin in IFN Naive Patients With Chronic Hepatitis C

Chronic Hepatitis C

China
CureTech Ltd
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Chronic Hepatitis C Genotype I Infection

Chronic Hepatitis C

Israel
Chengdu Kanghong Biotech Co., Ltd.

Unknown

An Open, Single-center, Safety and Efficacy Study of Conbercept in Patients With Very Low Vision Secondary to Wet Age-related Macular Degeneration (wAMD) (LAMP)

Very Low Vision Secondary to Wet Age-related Macular Degeneration

China
Tibotec BVBA

Completed

An Open-Label Study of Telaprevir Administered Every 12 or 8 Hours in Combination With One of Two Pegylated Interferons and Ribavirin in Treatment-Naive Genotype 1 Chronic Hepatitis C Participants

Chronic Hepatitis C

France, Spain, Belgium, Germany, Austria, Netherlands
King Fahad Medical City
King AbdulAziz City for Science and Technology

Completed

Advanced Metagenomic Analysis of Human Colonic Microbiota in Patients With Chronic GI Disorders

Irritable Bowel Syndrome | Crohn Disease | Colitis, Ulcerative | Colonic Neoplasms

Saudi Arabia
Bristol-Myers Squibb

Withdrawn

Phase 2b Study of BMS-986094 and Daclatasvir, With or Without Ribavirin for the Treatment of Patients With Chronic Hepatitis C

Hepatitis C Virus

United States
St. Jude Children's Research Hospital

Terminated

The Effects of Ankle Foot Orthoses on Gait Efficiency in Children With Acute Lymphoblastic Leukemia and Foot Drop

Acute Lymphoblastic Leukemia | Foot Drop

United States
Gilead Sciences

Terminated

Efficacy and Safety Study of GS-9450 Treatment for 6 Months in Patients With Chronic Hepatitis C Virus Infection

HCV Infection

United States, United Kingdom, Germany, Canada, Puerto Rico, Poland
Santaris Pharma A/S

Unknown

Miravirsen Study in Null Responder to Pegylated Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C

Hepatitis C

Puerto Rico

3

Subscribe